Merlijn van Breugel

Merlijn van Breugel is a researcher at the University of Groningen's Faculty of Medical Sciences, Department of Immunology, specializing in artificial intelligence applications for allergy and immunology. His work bridges computational methods with clinical immunology to develop predictive models for allergic diseases.

His research focuses on AI-driven allergy prediction using multi-omics data, particularly DNA methylation biomarkers for childhood allergic diseases. Key projects include the exquAIro initiative exploring clinical AI implementation, with emphasis on translating machine learning models into practical healthcare solutions. His fingerprint reveals strong expertise in Artificial Intelligence (100%), Allergy (100%), and Clinical Impact (60%) within immunology.

Research trends show progression from foundational multi-omics analysis (2021-2022) toward implementation challenges of AI in clinical settings (2023-2025). His publications consistently address the integration of machine learning with immunological data to improve diagnostic accuracy and personalized treatment strategies, with growing focus on real-world clinical adoption barriers.

He actively collaborates with international researchers including Koppelman, Nawijn, and Bønnelykke, with significant contributions to high-impact journals like Nature Communications and Journal of Allergy and Clinical Immunology. His 2025 academic presentation on the exquAIro initiative demonstrates ongoing leadership in AI medicine translation.